Press Releases

Date	Title	Company
06-Jan-2023	Poor glycemic control in patients with type 2 diabetes can be predicted from patient information systems with the help of machine learning	University of Eastern Finland
06-Jan-2023	New Year and two new zones at Pharmapack Europe in 2024	Pharmapack Europe
06-Jan-2023	Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes	Akili, Inc.
06-Jan-2023	Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration	Transgene
06-Jan-2023	Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma co-led by Arix to create best-in-class engineered cell therapy platform	Arix Bioscience plc
06-Jan-2023	CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs	CureVac
06-Jan-2023	New AI editing tool to speed up editing manuscripts	Cactus Communications
06-Jan-2023	Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes	Sartorius
06-Jan-2023	Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs	Synaffix B.V.
06-Jan-2023	PharmiWeb.Jobs Welcomes Carys Mills Consulting	Carys Mills Consulting
06-Jan-2023	Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent	Andrew Lloyd Associates
06-Jan-2023	HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations	HighTide Therapeutics Inc.
05-Jan-2023	Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes	B3C newswire
05-Jan-2023	Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma	Dermapharm Holding SE
05-Jan-2023	FDA accepts nirsevimab application as first protective option against RSV disease for all infants	Sanofi
05-Jan-2023	X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership	X-Chem
05-Jan-2023	Nitinol Medical Devices Market exhibiting CAGR of 9% by 2032, owing to increasing number of percutaneous coronary intervention (PCI) procedures \| insightSLICE	insightSLICE
05-Jan-2023	BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund	BioVersys
05-Jan-2023	Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer	Nouscom
05-Jan-2023	Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform	Adcendo ApS